Damora Therapeutics (DMRA) Share-based Compensation (2020 - 2026)
Damora Therapeutics' Share-based Compensation came in at $6.14 million for Q2 2026, compared with $172,000 a year earlier and up 96.0% from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Damora Therapeutics reported Share-based Compensation of $9.93 million, up 640.7% year-over-year; for FY2025, it was $998,000, down 69.2% from FY2024.
- Share-based Compensation has declined in each of the last three years, though with a five-year compound annual growth rate of 0.3% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $3.24 million in FY2024 (-40.3%), $5.43 million in FY2023 (-2.6%), $5.57 million in FY2022 (+24.4%) and $4.48 million in FY2021 (+356.2%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q3 2020.
- Year-over-year, Share-based Compensation increased in 1 of the last six quarters, with an average decline of 52.0%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2021 (growth of 816.5%), and the weakest in Q1 2025 (a decline of 86.8%).
- Business Quant data shows DMRA's Share-based Compensation at $3.13 million (Q1 2026), $483,000 (Q4 2025) and $164,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Damora Therapeutics | 1.28 Bn | -57.65 Mn | - | 6.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.14 Mn |
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 164,000.00 |
| Jun 30, 2025 | 172,000.00 |
| Mar 31, 2025 | 179,000.00 |
| Dec 31, 2024 | 308,000.00 |
| Sep 30, 2024 | 681,000.00 |
| Jun 30, 2024 | 891,000.00 |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 1.22 Mn |
API Access
Damora Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();